“MPI-1 Investment Limited Partnership” (“MPI”), the fund managed by MedVenture Partners, Inc., has completed its Series A investment as a lead investor totaling 150 Million Yen in Biomedical Solutions, Inc. (“BSI”), along with funds managed by JAFCO Co., Ltd. and Mizuho Capital Co., Ltd.
>>PDF File
